This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Webb, M. Articles by Mason, L. A. Search for Related Content PubMed PubMed Citation Articles by Webb, M. Articles by Mason, L. A. Social Bookmarking                         What's this?

Dyspnea assessment and management in hospice patients with pulmonary disorders

University of South Florida, College of Nursing, Tampa, Florida

Linda E. Moody, PhD, MPH, FAAN

University of South Florida, College of Nursing, Tampa, Florida

Linda A. Mason, MS, ARNP

University of South Florida, College of Nursing, Tampa, Florida

Accurate assessments and appropriate management of dyspnea are essential to provide improved quality of life for hospice patients. This study describes methods of assessing dyspnea and interventions used to manage dyspnea in 72 hospice patients with end-stage lung disease or lung cancer. The mean age of the sample was 72.46 years old and the majority was white (80 percent) and male (62 percent). Paired t-tests were used to compare mean scores on admission and near death for dyspnea severity, Karnofsky functional status, pain, and Mini-Mental Status scores. Results showed significant decline in functional and cognitive status, but no significant changes in dyspnea severity and pain. Dyspnea was often assessed subjectively with observational methods only. Use of inhalants, oxygen, positioning, steroids, and oral opioids were the most frequent therapies for dyspnea. Relaxation, guided imagery, and other complementary therapies were rarely used (five percent or less). Measurement of dyspnea needs to be done frequently by using standardized instruments to assess severity and degree of symptom distress as well as the effects of treatment. Clinical trials are needed to determine which dyspnea interventions are most effective in terminally ill patients. Guidelines such as those developed for pain management are needed for effectively managing dyspnea.

American Journal of Hospice and Palliative Medicine®, Vol. 17, No. 4, 259-264 (2000)
DOI: 10.1177/104990910001700412


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Allen, S. Raut, J. Woollard, and M. Vassallo Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis Palliative Medicine, March 1, 2005; 19(2): 128 - 130. [Abstract] [PDF]

				L. E. Moody, M. Webb, R. Cheung, and J. Lowell A focus group for caregivers of hospice patients with severe dyspnea American Journal of Hospice and Palliative Medicine, March 1, 2004; 21(2): 121 - 130. [Abstract] [PDF]